Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD
Clinical trial NCT03247543 · COMPLETED
Trial details
- NCT number
- NCT03247543
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2018-10-17
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.